Sanofi’s November 5 headline says the company raised earnings guidance. But the supplied facts don’t include the revised forecast or explain what changed.
The guidance increase is the main news for shareholders, though its scale and basis are unknown. Sanofi ADR closed at US$47.47, up 4.72% for the day.
Investor takeaway: Sanofi reportedly raised guidance, but without the new figures or supporting details, you can’t assess the financial impact.
Sanofi ADR
SNY.US
SNY.US
Sanofi ADR
WealthAwesomeMarket cap
$108.62B
P/E
22.6x
52W high
$49.91
52W low
$39.07
1W change
+12.38%
Beta
0.27
Analyst Price Targets
Based on 11 analysts covering SNY · as of Nov 4, 2026
Wall Street analysts forecast SNY stock price to rise 145.6% over the next 12 months.
Consensus
Buy3.91 / 5.00
Avg. Target
C$53.48
+145.6% Upside
Previously C$53.61 on Oct 19, 2026
Current Price
C$21.77
Last close
Analyst Breakdown (11 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on SNY's historical volatility
30-Day Vol
28.6%
Annualized
90-Day Vol
25.0%
Annualized
Trend (90d)
+36.1%
Annualized drift
90d Mean
C$54.00
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$49.55 | C$44.90 – C$54.69 |
| 60 trading days | C$51.73 | C$45.00 – C$59.47 |
| 90 trading days | C$54.00 | C$45.53 – C$64.06 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Sanofi closed at US$47.47
The ADR gained 4.72% on the day. Trading volume was 52,998 shares, compared with a 20-day average of 4,295,840.
Bull case
Higher guidance points to an improved earnings outlook. Its significance depends on how much Sanofi raised the forecast and which earnings measure changed.
Bear case
The supplied information includes no revised forecast, explanation, or financial breakdown. The headline alone doesn’t show how much expectations changed or what drove the increase.
What happened: headline reports higher guidance
Sanofi’s November 5 end-of-day headline says the company raised earnings guidance. No revised forecast, comparison with prior guidance, or explanation is provided. The headline confirms an increase, but not its size or terms. Investors will need Sanofi’s detailed announcement to assess the change. See the Sanofi ADR stock page.
What the numbers show: a US$47.47 close
Sanofi ADR closed at US$47.47, up 4.72% for the day. The stock gained 12.38% over one week and 20.15% over one month, while its year-to-date gain was 3.88%. These figures provide market context, but they don’t show that the guidance headline caused a particular price move.
Trading volume was 52,998 shares, compared with a 20-day average of 4,295,840. The reported volume comparison was 1.27x. The stock page lists a P/E of 22.5522 and a market capitalization of about US$108.6 billion. None of these figures shows the size of the guidance change. See the Sanofi ADR stock page for more company information.
What to watch next: the revised forecast
The key questions are which earnings measure Sanofi revised, how the new forecast compares with the previous one, and what assumptions or developments support the change. The supplied headline and facts don’t answer these questions. Until Sanofi provides the figures and explanation, the increase is clear, but its effect on earnings expectations remains unknown.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
